Perkins Coie Trust Company’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Perkins Coie Trust Company’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-200	Closed	-$11K	–	312
2017 Q4	$11K	Hold	200	–	–	0.01%	253
2017 Q3	$11K	Hold	200	–	–	0.01%	257
2017 Q2	$12K	Hold	200	–	–	0.01%	252
2017 Q1	$11K	Buy	+200	New	+$9.85K	0.01%	244

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Perkins Coie Trust Company's BIVV Position: Q1 2018 in Review

Perkins Coie Trust Company sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 200 shares — an estimated $11K sold.

Perkins Coie Trust Company first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $12K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Perkins Coie Trust Company reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Perkins Coie Trust Company sold 200 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $11K.
Perkins Coie Trust Company first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Perkins Coie Trust Company's Bioverativ Inc. Common Stock position peaked at $12K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Perkins Coie Trust Company's 13F filing for Q1 2018, filed 16 Apr 2018.